[HTML][HTML] The future of gene therapy for transfusion-dependent beta-thalassemia: The power of the lentiviral vector for genetically modified hematopoietic stem cells
P Rattananon, U Anurathapan, K Bhukhai… - Frontiers in …, 2021 - frontiersin.org
β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
P Rattananon, U Anurathapan… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
[HTML][HTML] The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem …
P Rattananon, U Anurathapan, K Bhukhai… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Abstract β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells.
P Rattananon, U Anurathapan, K Bhukhai… - Frontiers in …, 2021 - europepmc.org
Abstract β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
P Rattananon, U Anurathapan… - Frontiers in …, 2021 - mahidol.elsevierpure.com
Abstract β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
P Rattananon, U Anurathapan, K Bhukhai, S Hongeng - 2021 - repository.li.mahidol.ac.th
Abstract β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
imbalance of β-and α-globin chains and an excess of α chains. Defective erythroid …
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
P Rattananon, U Anurathapan, K Bhukhai… - … Perspectives in Cell …, 2022 - books.google.com
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the
Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells Page 59 MINI REVIEW …
Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells Page 59 MINI REVIEW …